Literature DB >> 31894430

Evaluation of the use of component separation in elderly patients: results of a large cohort study with 30-day follow-up.

S Docimo1, A Bates2, M Alteri2, M Talamini2, A Pryor2, K Spaniolas2.   

Abstract

BACKGROUND: The incidence of massive ventral hernias among the elderly will increase as the population ages. Advanced age is often viewed as a contraindication to elective hernia repair. A relationship between age and complications of component separation procedures for ventral hernias is not well established. This study evaluated the effect of age on the peri-operative safety of AWR.
METHODS: The 2005-2013 ACS-NSQIP participant use data were reviewed to compare surgical site infection (SSI), overall morbidity, and serious morbidity in non-emergent component separation procedures among all age groups. All patients were stratified into four age quartiles and evaluated. Baseline characteristics included age, body mass index (BMI) and ASA 3 or 4 criteria. Statistical analysis was performed using SPSS. Odds ratios (OR) and 95% confidence intervals were reported as appropriate.
RESULTS: 4485 patients were identified. Majority of the cases were clean (76.8%). Patients were divided into the following quartiles based on age. The older quartile had a mean age of 72.7 ± 4.87 years. There were baseline differences in BMI and chronic comorbidity severity (measured by incidence of ASA score of 3 or 4) between the age groups, with the oldest group having lower BMI but higher rate of ASA 3 or 4 (p < 0.0001 for both). The rate of postoperative SSI was significantly different between age quartile groups (ranging from 16.3% from the youngest group to 9.4% for the oldest group, p < 0.0001). After adjusting for other baseline differences, advanced age was independently associated with lower SSI rate (OR 0.55, 95% CI 0.41-0.73). There was no significant difference in overall morbidity (p = 0.277) and serious morbidity (p = 0.131) between groups.
CONCLUSION: AWR is being performed with safety across all age groups. In selected patients of advanced age, AWR can be performed with similar safety profile and low SSI rate.

Entities:  

Keywords:  Abdominal wall reconstruction; Hernia optimization; Hernia repair in elderly; Surgery in the elderly

Mesh:

Year:  2020        PMID: 31894430     DOI: 10.1007/s10029-019-02069-6

Source DB:  PubMed          Journal:  Hernia        ISSN: 1248-9204            Impact factor:   4.739


  6 in total

1.  Polypharmacy is predictive of postoperative complications in older adults undergoing ventral hernia repair.

Authors:  Timothy R Holden; Bradley S Kushner; Julia L Hamilton; Britta Han; Sara E Holden
Journal:  Surg Endosc       Date:  2022-02-19       Impact factor: 4.584

2.  Randomized control trial evaluating the use of a shared decision-making aid for older ventral hernia patients in the Geriatric Assessment and Medical Preoperative Screening (GrAMPS) Program.

Authors:  B S Kushner; T Holden; B Han; M Sehnert; A Majumder; J A Blatnik; S E Holden
Journal:  Hernia       Date:  2021-10-22       Impact factor: 2.920

3.  Wide variation in surgical techniques to repair incisional hernias: a survey of practice patterns among general surgeons.

Authors:  Simon MacDonald; Paul M Johnson
Journal:  BMC Surg       Date:  2021-05-24       Impact factor: 2.102

4.  Age-Related Risk Factors in Ventral Hernia Repairs: A Review and Call to Action.

Authors:  Julia Hamilton; Bradley Kushner; Sara Holden; Timothy Holden
Journal:  J Surg Res       Date:  2021-05-17       Impact factor: 2.417

5.  Geriatric assessment and medical preoperative screening (GrAMPS) program for older hernia patients.

Authors:  Bradley S Kushner; J Hamilton; B J Han; M Sehnert; T Holden; S E Holden
Journal:  Hernia       Date:  2021-04-04       Impact factor: 2.920

6.  Hemorrhoidectomy for elderly patients aged 75 years or more, before and after studies.

Authors:  Masateru Yamamoto; Masanobu Ikeda; Tomio Matsumoto; Masahiko Takemoto; Ryo Sumimoto; Tsuyoshi Kobayashi; Hideki Ohdan
Journal:  Ann Med Surg (Lond)       Date:  2020-05-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.